Identification of novel urea derivatives as PTP1B inhibitors: synthesis, biological evaluation and structure–activity relationships

MedChemComm
2013.0

Abstract

The protein tyrosine phosphatase 1B (PTP1B) is an attractive target for the treatment of type 2 diabetes. A series of substituted 1, 3 benzyl urea has been synthesized and evaluated for PTP1B inhibitory, antidiabetic and antidyslipidemic activities. The most active compound of the series 5b showed 79.4% PTP1B inhibition and 20.7% blood glucose lowering in STZ model. It also lowered the serum cholesterol level by 16.3 % and significantly increased the serum HDL-cholesterol by 46.8%. The high activity of the compound 5b.has been explained by docking studies.

Knowledge Graph

Similar Paper

Identification of novel urea derivatives as PTP1B inhibitors: synthesis, biological evaluation and structure–activity relationships
MedChemComm 2013.0
Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity
Bioorganic & Medicinal Chemistry 2009.0
Novel 2-aryl-naphtho[1,2-d]oxazole derivatives as potential PTP-1B inhibitors showing antihyperglycemic activities
European Journal of Medicinal Chemistry 2009.0
Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice
European Journal of Medicinal Chemistry 2013.0
Synthesis of protein tyrosine phosphatase 1B inhibitors: Model validation and docking studies
Bioorganic & Medicinal Chemistry Letters 2009.0
A dimeric urea of the bisabolene sesquiterpene from the Okinawan marine sponge Axinyssa sp. inhibits protein tyrosine phosphatase 1B activity in Huh-7 human hepatoma cells
Bioorganic & Medicinal Chemistry Letters 2016.0
Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking
Bioorganic & Medicinal Chemistry Letters 2016.0
Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B
Medicinal Chemistry Research 2013.0
Synthesis and evaluation of some novel isochroman carboxylic acid derivatives as potential anti-diabetic agents
European Journal of Medicinal Chemistry 2009.0